Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Feasibility of a Telematics Pre-operative Assessment in a Bariatric Surgery During Covid-19

23 luglio 2020 aggiornato da: Gianfranco Silecchia, University of Roma La Sapienza

Feasibility of a Telematics Pre-operative Assessment in a Bariatric Center of Excellence During Covid-19 Phase 2: a Prospective Observational Study

Coronavirus (COVID-19) is a respiratory disease caused by a newly discovered coronavirus, SARS-CoV-2. Several recent papers on the pandemic recognized obesity as a risk factor for the COVID-19 infection. Therefore, an effective treatment for obesity even during COVID-19 outbreak is needed. Bariatric surgery, is considered an effective treatment in the reduction of obesity-related comorbidities and mortality risk. However, during Covid-19 phase 1 (lockdown) the near totality of elective non-oncologic procedures, including bariatric surgery, has been postponed, and all the outpatients' visits too. Therefore, phase 1 led to completely change the way of managing the pre-operative multidisciplinary visits considering the hospital limitation access and the restriction. In the present study the investigators explored the use of telemedicine as a possible strategy to face this new situation.

Specifically, this study aims to test the efficacy of an online structured protocol based on pre-operative multidisciplinary assessment using telemedicine instruments. In particular, the primary end point is to test the feasibility of a telematics pre-operative work-up. The secondary end points are evaluating patient's compliance and satisfaction to the online assessment.

Panoramica dello studio

Stato

Sconosciuto

Descrizione dettagliata

Coronavirus (COVID-19) is a respiratory disease caused by a newly discovered coronavirus, SARS-CoV-2. In Italy the first person-to-person transmission was reported on February, 21, 2020. The North of Italy, became the epicentre of the outbreak in Europe, and Italy was one of the most affected Country in the World. As May, 5, 2020 the total number of positive Covid-19 in Italy was 212532, with 27400 deaths. Several recent papers on the pandemic recognized obesity as a risk factor for the COVID-19 infection. Furthermore, the Centre for Disease and Control Prevention report that people with diabetes, liver disease, chronic lung disease and cardiovascular disease are at higher risk for greater severity of COVID-19, and these are the most common obesity-related comorbidities too. In New York out of 3615 subjects with SARS-CoV-2 positive swab between March 4, and April 4, 21% had BMI 30-34 and 16% had BMI > 35.

This foreword underlines the need to guarantee gold standard treatment for obesity even during COVID-19 outbreak, including bariatric surgery, considered an effective treatment in the reduction of obesity-related comorbidities and mortality risk.

On March 9, 2020 started the phase 1 (lockdown) and the near totality of elective non-oncologic procedures has been postponed (including bariatric procedures) to increase capacity for in-patient beds and acute care.

The efforts during the unexpected and unexplored phase 1 were addressed how to properly prepare the phase 2, started on May,4, 2020. In fact, the Phase 1 led to completely change the way of managing the pre-operative multidisciplinary outpatient's visits considering the hospital limitation access and the restriction.

All the possible remote contact with patients has been explored, in order to face this new situation. The first challenge was: how to continue to support our patients seeking treatment of morbid obesity. Considering the lack of effective treatment for Covid-19 and the possibility of a new epidemic peak, new strategies to assess and treat morbid obesity patients are needed.

Among possible strategies telemedicine could be the answer. Previous studies showed the efficacy of telemedicine (telephone or videoconferences) in bariatric surgery treatment, but no studies have ever tested a structured protocol during the Covid-19 pandemic, even if it is strongly encouraged according to recent suggestions of scientific community in bariatric field.

This study aims to test the efficacy of an online structured protocol based on pre-operative multidisciplinary assessment using telemedicine instruments.

In particular, the primary end point is to test the feasibility of a telematics pre-operative work-up. The secondary end points are evaluating patient's compliance and satisfaction to the online assessment.

Materials and Methods Participants The protocol will be tested on 20 patients of the Bariatric Center of Excellence, "Sapienza" University of Rome. All patients, whose first contact was at the hospital before the lockdown for the surgical session, will be contacted starting from the booking list. Each patient will be contacted by phone in order to be informed about the online assessment procedure and to ask for consent.

Protocol The protocol consists in a three weekly one-to-one online sessions both for nutritional and psychological pre-operative assessment, using skype or whatsapp, and a face to face session (psychological, nutritional and surgical) for the final decision on the bariatric surgery suitability. The standard related to privacy, informed consent and setting will respect the more recent guidelines for online consultations.

The nutritional sessions will be structured as follow:

  1. a) Session 1 (30 minutes) All the patients will be previously instructed by telephone to collect a centimetre and a weighing scale to take the anthropometric measures and weight.

    During the first session the following data will be collected: weight history, previous diets attempts, physical activity and lifestyle habits, food intake modality (greed, chewing and distribution of meals), water intake, evacuation. In order to detect food intake and eating habits, a 7-days food diary will be explained and sent to the patients by email with an instruction sheet. One week later the patient will send the diary back.

    In session 1 anthropometric measures (body weight, waist and hip circumferences and referred height) will be collected: height and weight will be used to calculate body mass index (BMI) in order to categorize patient's obesity level. The patient will send a picture of the weight by e-mail, instead circumferences will be taken following the dietician's instruction, who observe through the video.

  2. a) Session 2 (30 minutes) A week later the patient will send the 7-days food diary and picture of the daily weight by e-mail. The dietician will work on the food diary focusing on the wrong eating habits and choices. Then a customized food plan will be created (Low Calorie Diet or Very Low Calorie Diet or Very Low Calorie Ketogenic Diet) in order to be followed for the next 2 weeks. The Very Low Calorie Ketogenic Diet will be prescribed in high risk patients. Than, will be asked to complete a new 7-days food diary and to send it back in 2 weeks. In addition, a physical activity program will be prescribed.
  3. a) Session 3 (30 minutes) After 14 days of diet, the patient's weight and the 7-days food diary will be collected and discussed. The dietician and the patient will also discuss on the reached results comparing with those expected in 3 sessions. Level of compliance to recommendations will be evaluated in order to proceed at the final session.

The psychological sessions will be structured as follow:

  1. b) Session 1 (50 minutes' interview + 40 minutes' psychometric questionnaires administration) During the first session psychological anamnesis (previous and recent psychopathological symptoms, somatic signs, any psychiatric or neurological pharmacotherapies, history of psychotherapies, significant life events, familiar psychopathology), life history, family structure and relations will be collected following National guidelines. The replicable online version of some psychometric questionnaires will be administered; in particular, Binge Eating Scale (BES) and Eating Attitude Test - 26 (EAT-26) to assess eating disorders, Hamilton for Depression (HAM-D) and Anxiety (HAM-A) to assess mood disorders, SIO- Obesity correlated Disability Test to assess quality of life. All questionnaires will be created using "google moduli", and the generated link to access to the online questionnaire will be sent to the patients by e-mail. The answers will be automatically uploaded on an excel sheet combined with "google moduli" questionnaire sheet. The administration will follow APA guidelines on psychological tele-assessment.
  2. b) Session 2 (50 minutes) In the second session the psychologist will discuss the questionnaires' results. Than, information on weight history and possible related significant life events, expectations on weight loss after surgery, motivation, and compliance to previous treatment will be collected.
  3. b) Session 3 (50 minutes) All the detected data, including compliance to nutritional recommendation and reached weight loss will be considered. The psychologist summarized the sessions 'contents, and discussed on the future expectation and changes after surgery. Level of compliance will be evaluated in order to proceed to the final session.

4) Final multidisciplinary session - one-to-one modality Respecting the interpersonal safety distance and all the recommended indications of phase 2 measures, final multidisciplinary sessions (psychological, nutritional and surgical) will be carried out at the hospital. All the team members will previously discuss each case, each possible online session observed problems, patients 'compliance and reached results compared to expected. Than, psychologist and dietician will carry on the one-to-one last session, discussing on patient's suitability/non suitability to surgery (according to the procedural guideline), and on all the steps to comply with (eg. diet changes, follow up timing, expected possible inconveniences or difficulties).

Expected results Less than 20% of rejection rate to the online assessment request and an high rate of continuation until the end of the assessment are expected. Furthermore, more than 50% of patients are expected to be compliant and satisfied with the online procedure.

Tipo di studio

Osservativo

Iscrizione (Anticipato)

20

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 65 anni (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione di probabilità

Popolazione di studio

Obese people asking for bariatric surgery, who are in the waiting list of the bariatric center

Descrizione

Inclusion Criteria:

  • not being positive to Covid-19 (according to Covid-19 telephone interview)
  • age >18 and <65 years
  • availability of a stable internet connection
  • having a mailbox and possibility to send and receive pdf documents via e-mail

Exclusion Criteria:

  • Not having a stable internet connection and a mailbox
  • not having practicality with telematic tools
  • having possible Covid-19 symptoms (according to Covid-19 telephone interview)

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: Altro
  • Prospettive temporali: Prospettiva

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Rejection rate (%)
Lasso di tempo: During the recruitment process
The rejection rate to the online assessment modality will be calculated (% of people who refuse to participate to the online assessment procedure).
During the recruitment process
Drop out rate
Lasso di tempo: 1 month
The drop out rate will be calculated (% of people who drop out during the assessment procedure)
1 month

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Excess Weight Loss percentage (EWL%)
Lasso di tempo: 1 month
The patient's compliance to the clinicians' indications will be evaluated considering an Excess Weight Loss (%) >=5% for each participant, which will be calculated according to this formula: 100% × (weight at session 1 - weight at session 4)/(weight at session 1 - ideal body weight). The percentage of people with an EWL>=%5 will be reported.
1 month
Satisfaction degree
Lasso di tempo: 3 weeks

A questionnaire on satisfaction degree was specifically created. It asked to participants the following questions:

  • Are you satisfied with the psychological and nutritional online assessment? YES/NO
  • Which was your level of satisfaction with the online assessment? from 0 to 10 (where 0 = not at all, 10 = very much)
  • How would you rate the quality of video calls? from 0 to 10 (where 0 = not of quality (I couldn't see/hear at all; ) 10 = excellent quality (I could see/hear well))
  • In your opinion, could an online pre-operative psychological and nutritional assessment be effective? YES/NO
  • Would you have preferred to carry out the psychological and nutritional assessment in person? YES/NO
  • Was it difficult to use electronic tools for filling in / sending questionnaires? YES/NO
  • In light of this pre-operative online evaluation, would you carry out post-operative psychological and nutritional follow-up using videocalls? YES/NO
3 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 giugno 2020

Completamento primario (Effettivo)

22 luglio 2020

Completamento dello studio (Anticipato)

31 luglio 2020

Date di iscrizione allo studio

Primo inviato

22 luglio 2020

Primo inviato che soddisfa i criteri di controllo qualità

23 luglio 2020

Primo Inserito (Effettivo)

24 luglio 2020

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

24 luglio 2020

Ultimo aggiornamento inviato che soddisfa i criteri QC

23 luglio 2020

Ultimo verificato

1 giugno 2020

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

No

Descrizione del piano IPD

There is not a plan to make IPD available.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi